WuXi AppTec Co. posted better-than-expected third-quarter revenue despite concerns over a US bill seeking to block the ...

We found a listing for a rather flashy electric motorcycle online that's selling for no more than $566, but things aren't as ...

As the Chinese contract manufacturer awaits the U.S. Senate’s consideration of the BIOSECURE Act, it has added 800 new ...

A hospital in Wuxi, Jiangsu province has been fined 58.95 million yuan ($8.24 million) and stripped of its operating license ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

About 30 media workers and influencers embarked on a media tour on Nov 5 at the renovated Nanquan Old Street in Wuxi, East ...

WuXi XDC Cayman Inc. ('WuXi XDC' or the 'Company', stock code: 2268.HK), a leading global CRDMO (Contract Research, ...

WuXi AppTec posted better-than-expected third-quarter revenue despite concerns over American legislation seeking to block the ...

SHANGHAI, Oct. 28, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO ...

Jefferies analyst Chris Lui maintained a Buy rating on WuXi AppTec Co., Ltd. Class H (2359 – Research Report) on October 25 and set a ...

(Bloomberg) -- WuXi AppTec Co. posted better-than-expected third-quarter revenue despite concerns over a US bill seeking to block the Chinese company from accessing federally-funded contracts.

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO ...